Search

Author/Creator Zhao, Davidson

1. Molecular characterization of AML‐MRC reveals TP53 mutation as an adverse prognostic factor irrespective of MRC‐defining criteria, TP53 allelic state, or TP53 variant allele frequency. (16th November 2022)

Authors:
Zhao, Davidson; Eladl, Entsar; Zarif, Mojgan; Capo‐Chichi, José‐Mario; Schuh, Andre; Atenafu, Eshetu; Minden, Mark; Chang, Hong
Journal:
Cancer medicine
Issue:
Volume 12:Number 6(2023)
Page Start:
6511
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. NPM1-mutated AML-MRC diagnosed on the basis of history of MDS or MDS/MPN frequently harbours secondary-type mutations and confers inferior outcome compared to AML with mutated NPM1. (July 2022)

Authors:
Zhao, Davidson; Zarif, Mojgan; Eladl, Entsar; Capo-Chichi, José-Mario; Smith, Adam C.; Atenafu, Eshetu G.; Tierens, Anne; Minden, Mark D.; Schuh, Andre; Chang, Hong
Journal:
Leukemia research
Issue:
Volume 118(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search